Login
Home / PHIL : OTC
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis News Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Philux Global Group Inc.

$0 +$0.00 (+9,900%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0 - $0
Year Range
$0$0
Market Cap
4.69M
AVG Volume
3.26M
Trailing/Forward PE
-0.5/-
PEG ratio
-0.01
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD)
02K4K6K23 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
Net Income (USD)
-3M-2M-1M023 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
Operating Income (USD)
-600K-400K-200K023 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
EBITDA (USD)
-3M-2M-1M023 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
Cash Flows (USD)
-2M-1M01M2M23 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
EPS (USD)
-0-0-0-0-023 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
Expenses (USD)
-400K-200K0200K400KSG&ACapex23 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
Cash & Debt (USD)
02M4M6M8MCashLong Term DebtShort Term Debt23 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
Debt ratios
-2-1.5-1-0.5023 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
Margins
-2000%-1500%-1000%-500%0%20 Q321 Q121 Q221 Q321 Q422 Q122 Q222 Q323 Q124 Q2
Return on Capital
0%10%20%30%40%23 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
Shares Outstanding
020B40B60B23 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
Book Value Per Share (USD)
-0-0-0-023 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
Total Assets (USD)
0200K400K600K23 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
Employee Count
0123420022009201220132014
Free Cash Flow Yield
-2500%-2000%-1500%-1000%-500%0%med -25.82%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Price to Sales
01000200030004000med 1458.69Feb 23May 23Sep 23Apr 24Jul 24Nov 24Feb 25
EV/EBITDA
3.544.555.5med 4.51Oct 16Oct 16Oct 16Nov 16Nov 16Nov 16
Price/Operating Cashflow
02505007501000med 42Apr 21Jun 21May 22Jul 22Sep 22Nov 22Jan 23
Price to Book
00.10.20.3med 0.14Mar 18Apr 18May 18Jun 18Aug 18Sep 18Oct 18
Philux Global Group Inc.
PHIL
Stockpicker

Video analysis: PHIL

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: PHIL

PHIL Partners with Biotechnology Leader, Evolved Health, to Launch New Day™ Skin Spray Direct-to-Patient Program

businesswire.com · 1 Sep 2026

PHIL Partners with Biotechnology Leader, Evolved Health, to Launch New Day™ Skin Spray Direct-to-Patient Program

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--PHIL and Evolved Health partner to launch New Day™ Skin Spray Direct-to-Patient, delivering novel atopic dermatitis prescription directly to patients.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.